Your browser doesn't support javascript.
loading
Long-Term Outcomes From a Randomized Dose Optimization Study of Chimeric Antigen Receptor Modified T Cells in Relapsed Chronic Lymphocytic Leukemia.
Frey, Noelle V; Gill, Saar; Hexner, Elizabeth O; Schuster, Stephen; Nasta, Sunita; Loren, Alison; Svoboda, Jakub; Stadtmauer, Edward; Landsburg, Daniel J; Mato, Anthony; Levine, Bruce L; Lacey, Simon F; Melenhorst, Jan Joseph; Veloso, Elizabeth; Gaymon, Avery; Pequignot, Edward; Shan, Xinhe; Hwang, Wei-Ting; June, Carl H; Porter, David L.
Afiliação
  • Frey NV; Cell Therapy and Transplant Program, Division of Hematology-Oncology, Department of Medicine, Philadelphia, PA.
  • Gill S; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
  • Hexner EO; Cell Therapy and Transplant Program, Division of Hematology-Oncology, Department of Medicine, Philadelphia, PA.
  • Schuster S; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
  • Nasta S; Center for Cellular Immunotherapies, Department of Pathology and Laboratory Medicine, Philadelphia, PA.
  • Loren A; Cell Therapy and Transplant Program, Division of Hematology-Oncology, Department of Medicine, Philadelphia, PA.
  • Svoboda J; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
  • Stadtmauer E; Cell Therapy and Transplant Program, Division of Hematology-Oncology, Department of Medicine, Philadelphia, PA.
  • Landsburg DJ; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
  • Mato A; Cell Therapy and Transplant Program, Division of Hematology-Oncology, Department of Medicine, Philadelphia, PA.
  • Levine BL; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
  • Lacey SF; Cell Therapy and Transplant Program, Division of Hematology-Oncology, Department of Medicine, Philadelphia, PA.
  • Melenhorst JJ; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
  • Veloso E; Cell Therapy and Transplant Program, Division of Hematology-Oncology, Department of Medicine, Philadelphia, PA.
  • Gaymon A; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
  • Pequignot E; Cell Therapy and Transplant Program, Division of Hematology-Oncology, Department of Medicine, Philadelphia, PA.
  • Shan X; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
  • Hwang WT; Cell Therapy and Transplant Program, Division of Hematology-Oncology, Department of Medicine, Philadelphia, PA.
  • June CH; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
  • Porter DL; Cell Therapy and Transplant Program, Division of Hematology-Oncology, Department of Medicine, Philadelphia, PA.
J Clin Oncol ; 38(25): 2862-2871, 2020 09 01.
Article em En | MEDLINE | ID: mdl-32298202
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Imunoterapia Adotiva Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Panamá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Imunoterapia Adotiva Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Panamá